Director, Immunology & Oncology Price Forecasting

AbbVie•Mettawa, IL

13d•$182,000 - $346,000

About The Position

The Director, Immunology & Oncology Price Forecasting leads the teams responsible for Gross-to-Net (GTN) forecasting, planning, analysis, and reporting for the Immunology and Oncology portfolios. The position is accountable for the preparation, review, and delivery of price forecasts and required schedules across Plan, LBE, and LRP cycles; evaluation of rebates, discounts, contracting assumptions, and price scenarios; and translation of forecast results into clear business implications for Commercial and Finance leadership. The Director partners closely with Market Access, Government Pricing, Strategic Pricing, Volume Forecasting, Brand Finance, Commercial teams, and Price Accounting to align assumptions and communicate a consistent net sales narrative. The role leads complex and critical processes, develops team capabilities, and maintains clear accountability across an organization of approximately 16 team members, including three direct reports.

Requirements

BA/BS in Finance, Accounting, or a related discipline.
12+ years of progressive Finance and/or Accounting experience, including demonstrated experience leading teams and complex cross-functional processes.
Ability to interact with and support senior management and partner effectively and independently in a matrix organization.
Strong leadership, organizational, analytical, problem-solving, planning, and decision-making skills.
Excellent interpersonal, verbal, written, and executive communication skills.
Strong Excel and PowerPoint technical and content-strategy skills.
Broad systems knowledge and the ability to support technology-enabled process improvement.
Ability to manage multiple activities and shifting priorities under tight timeframes.
Ability to make sound decisions with incomplete information and under conditions of ambiguity or uncertainty.
Highly motivated self-starter who can translate broad direction into high-quality analytical output.
Open to new ideas, creative, and committed to value-added and continuous-improvement principles.

Responsibilities

Lead end-to-end price forecasting, planning, and reporting for the Immunology and Oncology portfolios across Plan, LBE, and LRP cycles.
Own the accuracy, completeness, consistency, and supportability of portfolio price and Gross-to-Net (GTN) forecasts.
Direct the preparation, review, and delivery of product-level forecasts, planning schedules, and materials for key Brand and business review meetings.
Evaluate rebates, discounts, contracting assumptions, approved pricing strategies, and scenario analyses; ensure assumptions are aligned, documented, and consistently applied.
Translate forecast results into clear business insights, including key drivers, variances, risks, trade-offs, opportunities, and recommended actions.
Provide timely financial leadership and decision support to senior management, Business Unit Controllers, Business Unit Presidents, and cross-functional partners.
Deliver a clear, consistent, and decision-ready price and GTN narrative tailored to executive and operational audiences.
Partner closely with Volume Forecasting, Commercial Finance, Market Access, Government Pricing, Strategic Pricing, Brand Finance, Price Accounting, and the Price Center of Excellence to align assumptions and develop a consolidated net sales outlook.
Lead oversight of GTN accounting reserves and related balance-sheet processes in partnership with Price Accounting and the Price Center of Excellence.
Maintain a strong control environment, ensuring compliance with financial policies, SOX requirements, audit expectations, and documented forecasting and accounting procedures.
Drive operational excellence through process standardization, automation, continuous improvement, and effective implementation of forecasting and reporting systems.
Lead, coach, and develop an organization of approximately 16 team members, including three direct reports, while establishing clear priorities, accountability, and a scalable operating model.